Total synthesis of (±)-agelastatin A, A potent inhibitor of osteopontin-mediated neoplastic transformations

Organic Letters

Volumn 11, Issue 6, 2009, Pages 1341-1344

  Dickson, David P ^a   Wardrop, Duncan J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGELASTATIN A; ALKALOID; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; OSTEOPONTIN; OXAZOLIDINONE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CATALYSIS; MOLECULAR STRUCTURE; OSTEOPONTIN; OXAZOLIDINONES; STEREOISOMERISM;

EID: 64049086842     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900133v     Document Type: Article

References (56)

1. Faulkner, D. J. Nat. Prod. Rev. 2002, 19, 1.
2. For recent reviews of synthetic efforts towards pyrrole-imidazole alkaloids, see: (a) Hoffmann, H.; Lindel, T. Synthesis 2003, 1753.
3. (b) Weinreb, S. M. Nat. Prod. Rep. 2007, 24, 931.
4. (c) Arndt, H. D.; Riedrich, M. Angew. Chem., Int. Ed. 2008, 47, 4785.
5. D'Ambrosio, M.; Guerriero, A.; Debitus, C.; Ribes, O.; Pusset, J.; Leroy, S.; Pietra, F. Chem. Commun. 1993, 1305.
6. (a) D'Ambrosio, M.; Guerriero, A.; Chiasera, G.; Pietra, F. Helv. Chim. Acta 1994, 77, 1895.
7. (b) D'Ambrosio, M.; Guerriero, A.; Ripamonti, M.; Debitus, C.; Waikedre, J.; Pietra, F. Helv. Chim. Acta 1996, 79, 727.
8. Pettit, G. R.; Ducki, S.; Herald, D. L.; Doubek, D. L.; Schmidt, J. M.; Chapuis, J. C. Oncol. Res. 2005, 15, 11.
9. Hong, T. W.; Jímenez, D. R.; Molinski, T. F. J. Nat. Prod. 1998, 61, 158-161.
10. Al Mourabit, A.; Potier, P. Eur. J. Org. Chem. 2001, 237.
11. Araki, A.; Tsuda, M.; Kubota, T.; Mikami, Y.; Fromont, J.; Kobayashi, J. Org. Lett. 2007, 9, 2369.
12. Meijer, L.; Thunnissen, A. M.; White, A. W.; Garnier, M.; Nikolic, M.; Tsai, L. H.; Walter, J.; Cleverley, K. E.; Salinas, P. C.; Wu, Y. Z.; Biernat, J.; Mandelkow, E. M.; Kim, S. H.; Pettit, G. R. Chem. Biol. 2000, 7, 51.
13. Huang, H.-C.; O'Brien, W. T.; Klein, P. S. Drug Discovery Today: Ther. Strategies 2006, 3, 613.
14. Kozikowski, A. P.; Gaisina, I. N.; Yuan, H.; Petukhov, P. A.; Blond, S. Y.; Fedolak, A.; Caldarone, B.; McGonigle, P. J. Am. Chem. Soc. 2007, 129, 8328.
15. Hale, K. J.; Domostoj, M. M.; El-Tanni, M.; Campbell, F. C.; Mason, C. K. Total Synthesis And Mechanism Of Action Studies On The Antitumor Alkaloid (-) -Agelastatin A In Strategies and Tactics in Organic Synthesis; Harmata, M., Ed.; Elsevier Academic Press: London, 2005; Vol.
16. 6, p 352.
17. Mason, C. K.; McFarlane, S.; Johnston, P. G.; Crowe, P.; Erwin, P. J.; Domostoj, M. M.; Campbell, F. C.; Manaviazar, S.; Hale, K. J.; El-Tanani, M. Mol. Cancer Ther. 2008, 7, 548.
18. Osteopontin is an extracellular structural glycoprotein implicated in playing a fundamental role in mediating tumor metastasis: Weber, G. F. Cancer Lett. 2008, 270, 181.
19. For a review of these efforts, see ref 2b.
20. Stien, D.; Anderson, G. T.; Chase, C. E.; Koh, Y.; Weinreb, S. M. J. Am. Chem. Soc. 1999, 121, 9574.
21. (a) Feldman, K. S.; Saunders, J. C. J. Am. Chem. Soc. 2002, 124, 9060.
22. (b) Feldman, K. S.; Saunders, J. C.; Wrobleski, M. L. J. Org. Chem. 2002, 67, 7096.
23. (a) Domostoj, M. M.; Irving, E.; Scheinmann, F.; Hale, K. J. Org. Lett. 2004, 6, 2615.
24. (b) Hale, K. J.; Domostoj, M. M.; Tocher, D. A.; Irving, E.; Scheinmann, F. Org. Lett. 2003, 5, 2927.
25. Davis, F. A.; Deng, J. Org. Lett. 2005, 7, 621.
26. Trost, B. M.; Dong, G. J. Am. Chem. Soc. 2006, 128, 6054.
27. Ichikawa, Y.; Yamaoka, T.; Nakano, K.; Kotsuki, H. Org. Lett. 2007, 9, 2989.
28. (a) Yoshimitsu, T.; Ino, T.; Tanaka, T. Org. Lett. 2008, 10, 5457. For a related approach, see:
29. (b) Baron, E.; O'Brien, P.; Towers, T. D. Tetrahedron Lett. 2002, 43, 723.
30. Al-Mourabit, A.; Potier, P. Eur. J. Org. Chem. 2001, 237.
31. For reviews, see: (a) Knapp, S. Chem. Soc. Rev. 1999, 28, 61.
32. (b) Robin, S.; Rousseau, G. Tetrahedron 1998, 54, 13681.
33. (c) Cardillo, G.; Orena, M. Tetrahedron 1990, 46, 3321.
34. (a) Deardorff, D. R.; Shambayati, S.; Myles, D. C.; Heerding, D. J. Org. Chem. 1988, 53, 3614.
35. (b) Deardorff, D. R.; Myles, D. C. Org. Synth. Coll. Vol. VIII 1993, 13.
36. Overman, L. E.; Carpenter, N. E. The Allylic Trihaloacetimidate Rearrangement. In Organic Reactions; Overman, L. E., Ed.; John Wiley and Sons, Inc., 2005; Vol 66, pp 1-107.
37. Conventional methods of trichloroacetamide cleavage, include:
38. (a) Goody, R. S.; Walker, R. T. Tetrahedron Lett. 1967, 8, 289 (NaOH).
39. 3).
40. (c) Nishikawa, T.; Urabe, D.; Isobe, M. Angew. Chem., Int. Ed. 2004, 43, 4782 (DIBAL-H).
41. (d) Singh, O. V.; Han, H. Org. Lett. 2004, 6, 3067 (Na-Hg).
42. (a) Nishikawa, T.; Ohyabu, N.; Yamamoto, N.; Isobe, M. Tetrahedron 1999, 55, 4325.
43. (b) Nishikawa, T.; Urabe, D.; Tomita, M.; Tsujimoto, T.; Iwabuchi, T.; Isobe, M. Org. Lett. 2006, 8, 3263.
44. (a) Atanasova, I.; Petrov, Y.; Mollov, N. Synthesis 1987, 734.
45. (b) Braverman, S.; Cherkinsky, M.; Kedrova, L.; Reiselman, A. Tetrahedron Lett. 1999, 40, 3235.
46. Ovaa, H.; Lastdrager, B.; Codee, J. D. C.; van der Marel, G. A.; Overkleeft, H. S.; van Boom, J. H. J. Chem. Soc., Perkin Trans. 1 2002, 2370.
47. (a) Cardillo, G.; Orena, M.; Sandri, S. Chem. Commun. 1983, 1489.
48. (b) Commerçon, A.; Ponsinet, G. Tetrahedron Lett. 1990, 31, 3871.
49. (c) Galeazzi, R.; Martelli, G.; Orena, M.; Rinaldi, S. Synthesis 2004, 2560.
50. Yeung, Y. Y.; Gao, X.; Corey, E. J. J. Am. Chem. Soc. 2006, 128, 9644.
51. The success of NBA in mediating the cyclization of 8 may stem from the increased basicity (relative to succinimidyl or halide ions) of the acetamide anion generated upon brominium ion formation, which, through deprotonation, would serve to increase the nucleophilicity of the trichloroacetamide group. The use of NBA also minimizes the halide ion concentration and thus formation of the dihalide addition product: Corey, E. J.; Loh, T. P.; AchyuthaRao, S.; Daley, D. C.; Sarshar, S. J. Org. Chem. 1993, 58, 5600.
52. Asai, M.; Nishikawa, T.; Ohyabu, N.; Yamamoto, N.; Isobe, M. Tetrahedron 2001, 57, 4543.
53. Shull, B. K.; Sakai, T.; Nichols, J. B.; Koreeda, M. J. Org. Chem. 1997, 62, 8294.
54. 3, as previously reported: Urabe, D.; Sugino, K.; Nishikawa, T.; Isobe, M Tetrahedron Lett. 2004, 45, 9405.
55. More, J. D.; Finney, N. S. Org. Lett. 2002, 4, 3001.
56. Caddick, S.; Khan, S.; Frost, L. M.; Smith, N. J.; Cheung, S.; Pairaudeau, G. Tetrahedron 2000, 56, 8953.